Mustang Bio, Inc. has just released the following news:
Mustang Bio Announces First Patient Successfully Treated by Ex Vivo Lentiviral Gene Therapy to Treat RAG1 Severe Combined Immunodeficiency
Click here to read the full article
If you have any questions, or would like to contact Investor Relations, please reply to this email.
Mustang Bio, Inc.377 Plantation Street, 1st Floor, Worcester, MA 01605 United States of America
https://www.mustangbio.com